Alendronate sodium trihydrate

• Catalog No.: A4978
• CAS Number: 121268-17-5
• M. F.: C4H18NNaO10P2
• M. W.: 325.123712
• Purity: ≥97% (NMR)

SYNONYMS

• IUPAC name: sodium trihydrate hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate
• IUPAC Traditional name: sodium trihydrate alendronate(1-)
• Synonyms: 4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium; MK-217

DATABASE IDS

• CAS Number: 121268-17-5
• MDL Number: MFCD01748233
• PubChem SID: 24724391

PROPERTIES

• Empirical Formula (Hill Notation): C4H12NaNO7P2 · 3 H2O
• Purity: ≥97% (NMR)
• Apperance: white powder
• Solubility: water, double-distilled: soluble10 mg/mL
• GHS Signal Word: Warning
• GHS Hazard statements: H302
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• Risk Statements: 22
• RTECS: SZ6523500
• Storage Temperature: -20°C
• German water hazard class: 3

DETAILS

Description (English)

Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor.
Application
Alendronate sodium trihydrate is a bone resorption inhibitor, farnesyl diphosphate synthase inhibitor and CD45 protein tyrosine phosphatase inhibitor.

Description (简体中文)

Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Biochem/physiol Actions
Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor.
Application
Alendronate sodium trihydrate is a bone resorption inhibitor, farnesyl diphosphate synthase inhibitor and CD45 protein tyrosine phosphatase inhibitor.